No-Observed-Adverse-Effect Level
"No-Observed-Adverse-Effect Level" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The highest dosage administered that does not produce toxic effects.
| Descriptor ID |
D019055
|
| MeSH Number(s) |
E05.940.600 G07.690.936.750
|
| Concept/Terms |
No-Observed-Adverse-Effect Level- No-Observed-Adverse-Effect Level
- Level, No-Observed-Adverse-Effect
- Levels, No-Observed-Adverse-Effect
- No Observed Adverse Effect Level
- No-Observed-Adverse-Effect Levels
- NOAEL
No-Observed-Effect Level- No-Observed-Effect Level
- Level, No-Observed-Effect
- Levels, No-Observed-Effect
- No Observed Effect Level
- No-Observed-Effect Levels
Acceptable Daily Intake- Acceptable Daily Intake
- Acceptable Daily Intakes
- Daily Intake, Acceptable
- Daily Intakes, Acceptable
- Intake, Acceptable Daily
- Intakes, Acceptable Daily
- Tolerable Daily Intake
- Daily Intake, Tolerable
- Daily Intakes, Tolerable
- Intake, Tolerable Daily
- Intakes, Tolerable Daily
- Tolerable Daily Intakes
|
Below are MeSH descriptors whose meaning is more general than "No-Observed-Adverse-Effect Level".
Below are MeSH descriptors whose meaning is more specific than "No-Observed-Adverse-Effect Level".
This graph shows the total number of publications written about "No-Observed-Adverse-Effect Level" by people in this website by year, and whether "No-Observed-Adverse-Effect Level" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "No-Observed-Adverse-Effect Level" by people in Profiles.
-
Acute and Subacute Toxicity Assessment of Andrographolide-2-hydroxypropyl-ß-cyclodextrin Complex via Oral and Inhalation Route of Administration in Sprague-Dawley Rats. ScientificWorldJournal. 2022; 2022:6224107.
-
Oral toxicity and pharmacokinetic studies of SHetA2, a new chemopreventive agent, in rats and dogs. Drug Chem Toxicol. 2013 Jul; 36(3):284-95.